{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:01:56Z","timestamp":1794405716895,"version":"4.9.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007631","name":"Canadian Institute for Advanced Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007631","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009017","name":"ALS Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009408","name":"Fondation Brain Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>TDP-43 proteinopathy is a pathological hallmark of many neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). So far, there is no therapy available for these neurodegenerative diseases. In addition, the impact of TDP-43 proteinopathy on neuronal translational profile also remains unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Biochemical, immunohistology and assay-based studies were done with cell cultures and transgenic mice models. We also used Ribotag with microarray and proteomic analysis to determine the neuronal translational profile in the mice model of ALS\/FTD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Here, we report that oral administration of a novel analog (IMS-088) of withaferin-A, an antagonist of nuclear factor kappa-B (NF-\u0138B) essential modulator (NEMO), induced autophagy and reduced TDP-43 proteinopathy in the brain and spinal cord of transgenic mice expressing human TDP-43 mutants, models of ALS\/FTD. Treatment with IMS-088 ameliorated cognitive impairment, reduced gliosis in the brain of ALS\/FTD mouse models. With the Ribotrap method, we investigated the impact of TDP-43 proteinopathy and IMS-088 treatment on the translation profile of neurons of one-year old hTDP-43\n                      <jats:sup>A315T<\/jats:sup>\n                      mice. TDP-43 proteinopathy caused translational dysregulation of specific mRNAs including translational suppression of neurofilament mRNAs resulting in 3 to 4-fold decrease in levels type IV neurofilament proteins. Oral administration of IMS-088 rescued the translational defects associated with TDP-43 proteinopathy and restored the synthesis of neurofilament proteins, which are essential for axon integrity and synaptic function.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study revealed that induction of autophagy reduces TDP-43 pathology and ameliorates the translational defect seen in mice models of ALS\/FTD. Based on these results, we suggest IMS-088 and perhaps other inducers of autophagy should be considered as potential therapeutics for neurodegenerative disorders with TDP-43 proteinopathies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13024-020-00420-5","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T11:03:46Z","timestamp":1610017426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Induction of autophagy mitigates TDP-43 pathology and translational repression of neurofilament mRNAs in mouse models of ALS\/FTD"],"prefix":"10.1186","volume":"16","author":[{"given":"Sunny","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Phaneuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Pierre","family":"Cordeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hejer","family":"Boutej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasna","family":"Kriz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9072-5667","authenticated-orcid":false,"given":"Jean-Pierre","family":"Julien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"420_CR1","doi-asserted-by":"publisher","unstructured":"Buratti E. Advances in genetics, vol. 91: Elsevier; 2015. p. 1\u201353. https:\/\/doi.org\/10.1016\/bs.adgen.2015.07.001.","DOI":"10.1016\/bs.adgen.2015.07.001"},{"key":"420_CR2","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.celrep.2019.04.003","volume":"27","author":"EY Liu","year":"2019","unstructured":"Liu EY, et al. Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons. Cell Rep. 2019;27:1409\u20131421. e1406.","journal-title":"Cell Rep"},{"key":"420_CR3","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1172\/JCI123931","volume":"129","author":"S Pozzi","year":"2019","unstructured":"Pozzi S, et al. Virus-mediated delivery of antibody targeting TAR DNA-binding protein-43 mitigates associated neuropathology. J Clin Invest. 2019;129:1581\u201395.","journal-title":"J Clin Invest"},{"key":"420_CR4","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai T, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602\u201311.","journal-title":"Biochem Biophys Res Commun"},{"key":"420_CR5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/neup.12138","volume":"34","author":"T Arai","year":"2014","unstructured":"Arai T. Significance and limitation of the pathological classification of TDP-43 proteinopathy. Neuropathology. 2014;34:578\u201388.","journal-title":"Neuropathology"},{"key":"420_CR6","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(16)00737-6","volume":"388","author":"JR Burrell","year":"2016","unstructured":"Burrell JR, et al. The frontotemporal dementia-motor neuron disease continuum. Lancet. 2016;388:919\u201331.","journal-title":"Lancet"},{"key":"420_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/jnc.13588","volume":"138","author":"IR Mackenzie","year":"2016","unstructured":"Mackenzie IR, Neumann M. Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies. J Neurochem. 2016;138:54\u201370.","journal-title":"J Neurochem"},{"key":"420_CR8","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1021\/pr901076y","volume":"9","author":"BD Freibaum","year":"2010","unstructured":"Freibaum BD, Chitta RK, High AA, Taylor JP. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res. 2010;9:1104\u201320.","journal-title":"J Proteome Res"},{"key":"420_CR9","doi-asserted-by":"publisher","first-page":"15962","DOI":"10.1523\/JNEUROSCI.2526-14.2014","volume":"34","author":"AN Coyne","year":"2014","unstructured":"Coyne AN, et al. Futsch\/MAP 1B mRNA is a translational target of TDP-43 and is neuroprotective in a Drosophila model of amyotrophic lateral sclerosis. J Neurosci. 2014;34:15962\u201374.","journal-title":"J Neurosci"},{"key":"420_CR10","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00401-016-1603-8","volume":"132","author":"P Majumder","year":"2016","unstructured":"Majumder P, Chu J-F, Chatterjee B, Swamy KB, Shen C-KJ. Co-regulation of mRNA translation by TDP-43 and fragile X syndrome protein FMRP. Acta Neuropathol. 2016;132:721\u201338.","journal-title":"Acta Neuropathol"},{"key":"420_CR11","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/hmg\/ddx035","volume":"26","author":"A Russo","year":"2017","unstructured":"Russo A, et al. Increased cytoplasmic TDP-43 reduces global protein synthesis by interacting with RACK1 on polyribosomes. Hum Mol Genet. 2017;26:1407\u201318.","journal-title":"Hum Mol Genet"},{"key":"420_CR12","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1093\/brain\/awr159","volume":"134","author":"V Swarup","year":"2011","unstructured":"Swarup V, et al. Pathological hallmarks of amyotrophic lateral sclerosis\/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. Brain. 2011;134:2610\u201326.","journal-title":"Brain"},{"key":"420_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40478-016-0340-5","volume":"4","author":"V Picher-Martel","year":"2016","unstructured":"Picher-Martel V, Valdmanis PN, Gould PV, Julien J-P, Dupr\u00e9 N. From animal models to human disease: a genetic approach for personalized medicine in ALS. Acta Neuropathol Commun. 2016;4:70.","journal-title":"Acta Neuropathol Commun"},{"key":"420_CR14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s13311-016-0499-2","volume":"14","author":"K Dutta","year":"2017","unstructured":"Dutta K, Patel P, Rahimian R, Phaneuf D, Julien J-P. Withania somnifera reverses transactive response DNA binding protein 43 proteinopathy in a mouse model of amyotrophic lateral sclerosis\/frontotemporal lobar degeneration. Neurotherapeutics. 2017;14:447\u201362.","journal-title":"Neurotherapeutics"},{"key":"420_CR15","doi-asserted-by":"publisher","first-page":"15024","DOI":"10.1073\/pnas.1206362109","volume":"109","author":"I-F Wang","year":"2012","unstructured":"Wang I-F, et al. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc Natl Acad Sci. 2012;109:15024\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"420_CR16","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1084\/jem.20111313","volume":"208","author":"V Swarup","year":"2011","unstructured":"Swarup V, et al. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor \u03baB\u2013mediated pathogenic pathways. J Exp Med. 2011;208:2429\u201347.","journal-title":"J Exp Med"},{"key":"420_CR17","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.neuron.2014.01.013","volume":"81","author":"AE Frakes","year":"2014","unstructured":"Frakes AE, et al. Microglia induce motor neuron death via the classical NF-\u03baB pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009\u201323.","journal-title":"Neuron"},{"key":"420_CR18","first-page":"1","volume":"208","author":"MR Banu","year":"2020","unstructured":"Banu MR, Ibrahim M, Prabhu K, Rajasankar S. Withaferin-A protects the nigral dopamine neuron and recovers motor activity in aged rats. Cells Tissues Organs. 2020;208:1\u20137.","journal-title":"Cells Tissues Organs"},{"key":"420_CR19","doi-asserted-by":"publisher","first-page":"33161","DOI":"10.1074\/jbc.M114.582478","volume":"289","author":"C Hooper","year":"2014","unstructured":"Hooper C, Jackson SS, Coughlin EE, Coon JJ, Miyamoto S. Covalent modification of the NF-\u03baB essential modulator (NEMO) by a chemical compound can regulate its ubiquitin binding properties in vitro. J Biol Chem. 2014;289:33161\u201374.","journal-title":"J Biol Chem"},{"key":"420_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0031-9384(02)00979-4","volume":"78","author":"K Yamada","year":"2003","unstructured":"Yamada K, Santo-Yamada Y, Wada K. Stress-induced impairment of inhibitory avoidance learning in female neuromedin B receptor-deficient mice. Physiol Behav. 2003;78:303\u20139.","journal-title":"Physiol Behav"},{"key":"420_CR21","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1093\/brain\/aww237","volume":"139","author":"Y Iguchi","year":"2016","unstructured":"Iguchi Y, et al. Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain. 2016;139:3187\u2013201.","journal-title":"Brain"},{"key":"420_CR22","doi-asserted-by":"publisher","first-page":"30604","DOI":"10.1074\/jbc.270.51.30604","volume":"270","author":"G Charron","year":"1995","unstructured":"Charron G, Guy L-G, Bazinet M, Julien J-P. Multiple neuron-specific enhancers in the gene coding for the human neurofilament light chain. J Biol Chem. 1995;270:30604\u201310.","journal-title":"J Biol Chem"},{"key":"420_CR23","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.cell.2008.10.029","volume":"135","author":"JP Doyle","year":"2008","unstructured":"Doyle JP, et al. Application of a translational profiling approach for the comparative analysis of CNS cell types. Cell. 2008;135:749\u201362.","journal-title":"Cell"},{"key":"420_CR24","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1016\/j.celrep.2017.11.058","volume":"21","author":"H Boutej","year":"2017","unstructured":"Boutej H, et al. Diverging mRNA and protein networks in activated microglia reveal SRSF3 suppresses translation of highly upregulated innate immune transcripts. Cell Rep. 2017;21:3220\u201333.","journal-title":"Cell Rep"},{"key":"420_CR25","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.nbd.2011.12.002","volume":"45","author":"Y Iguchi","year":"2012","unstructured":"Iguchi Y, et al. Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies. Neurobiol Dis. 2012;45:862\u201370.","journal-title":"Neurobiol Dis"},{"key":"420_CR26","first-page":"629","volume":"1","author":"A Trocoli","year":"2011","unstructured":"Trocoli A, Djavaheri-Mergny M. The complex interplay between autophagy and NF-\u03baB signaling pathways in cancer cells. Am J Cancer Res. 2011;1:629.","journal-title":"Am J Cancer Res"},{"key":"420_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40478-015-0212-4","volume":"3","author":"JC Mitchell","year":"2015","unstructured":"Mitchell JC, et al. Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS. Acta Neuropathol Commun. 2015;3:36.","journal-title":"Acta Neuropathol Commun"},{"key":"420_CR28","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson PT, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019;142:1503\u201327.","journal-title":"Brain"},{"key":"420_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0092-8674(93)90158-M","volume":"73","author":"F C\u00f4t\u00e9","year":"1993","unstructured":"C\u00f4t\u00e9 F, Collard J-F, Julien J-P. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell. 1993;73:35\u201346.","journal-title":"Cell"},{"key":"420_CR30","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/0896-6273(94)90263-1","volume":"13","author":"MK Lee","year":"1994","unstructured":"Lee MK, Marszalek JR, Cleveland DW. A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron. 1994;13:975\u201388.","journal-title":"Neuron"},{"key":"420_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/375061a0","volume":"375","author":"J-F Collard","year":"1995","unstructured":"Collard J-F, C\u00f4t\u00e9 F, Julien J-P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature. 1995;375:61\u20134.","journal-title":"Nature"},{"key":"420_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0962-8924(97)01049-0","volume":"7","author":"J-P Julien","year":"1997","unstructured":"Julien J-P. Neurofilaments and motor neuron disease. Trends Cell Biol. 1997;7:243\u20139.","journal-title":"Trends Cell Biol"},{"key":"420_CR33","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1083\/jcb.147.3.531","volume":"147","author":"JM Beaulieu","year":"1999","unstructured":"Beaulieu JM, Nguyen MD, Julien JP. Late onset of motor neurons in mice overexpressing wild-type peripherin. J Cell Biol. 1999;147:531\u201344.","journal-title":"J Cell Biol"},{"key":"420_CR34","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/mp.2015.45","volume":"20","author":"A Yuan","year":"2015","unstructured":"Yuan A, et al. Neurofilament subunits are integral components of synapses and modulate neurotransmission and behavior in vivo. Mol Psychiatry. 2015;20:986\u201394.","journal-title":"Mol Psychiatry"},{"key":"420_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-018-0194-7","volume":"8","author":"A Yuan","year":"2018","unstructured":"Yuan A, et al. Neurofilament light interaction with GluN1 modulates neurotransmission and schizophrenia-associated behaviors. Transl Psychiatry. 2018;8:1\u201312.","journal-title":"Transl Psychiatry"},{"key":"420_CR36","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.mcn.2007.03.007","volume":"35","author":"MJ Strong","year":"2007","unstructured":"Strong MJ, et al. TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol Cell Neurosci. 2007;35:320\u20137.","journal-title":"Mol Cell Neurosci"},{"key":"420_CR37","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.tiv.2017.07.025","volume":"44","author":"K Ghosh","year":"2017","unstructured":"Ghosh K, et al. Withaferin a induced impaired autophagy and unfolded protein response in human breast cancer cell-lines MCF-7 and MDA-MB-231. Toxicol in Vitro. 2017;44:330\u20138.","journal-title":"Toxicol in Vitro"},{"key":"420_CR38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s13311-014-0311-0","volume":"12","author":"P Patel","year":"2015","unstructured":"Patel P, Julien J-P, Kriz J. Early-stage treatment with Withaferin a reduces levels of misfolded superoxide dismutase 1 and extends lifespan in a mouse model of amyotrophic lateral sclerosis. Neurotherapeutics. 2015;12:217\u201333.","journal-title":"Neurotherapeutics"},{"key":"420_CR39","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.advms.2016.09.003","volume":"62","author":"Q-Z Zhang","year":"2017","unstructured":"Zhang Q-Z, et al. Protection against cerebral infarction by Withaferin a involves inhibition of neuronal apoptosis, activation of PI3K\/Akt signaling pathway, and reduced intimal hyperplasia via inhibition of VSMC migration and matrix metalloproteinases. Adv Med Sci. 2017;62:186\u201392.","journal-title":"Adv Med Sci"},{"key":"420_CR40","doi-asserted-by":"publisher","first-page":"e44419","DOI":"10.1371\/journal.pone.0044419","volume":"7","author":"K Vaishnavi","year":"2012","unstructured":"Vaishnavi K, et al. Differential activities of the two closely related withanolides, Withaferin A and Withanone: bioinformatics and experimental evidences. PloS one. 2012;7:e44419.","journal-title":"PloS one"},{"key":"420_CR41","first-page":"2167","volume":"4","author":"C Huang","year":"2015","unstructured":"Huang C, et al. 3beta-methoxy derivation of Withaferin-a attenuates its anticancer potency: bioinformatics and molecular evidences. Med Aromat Plants. 2015;4:2167\u20130412.100021.","journal-title":"Med Aromat Plants"},{"key":"420_CR42","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1021\/acs.jnatprod.7b00573","volume":"80","author":"A Chaudhary","year":"2017","unstructured":"Chaudhary A, et al. 2, 3-Dihydro-3\u03b2-methoxy Withaferin-a protects normal cells against stress: molecular evidence of its potent cytoprotective activity. J Nat Prod. 2017;80:2756\u201360.","journal-title":"J Nat Prod"},{"key":"420_CR43","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/ng1362","volume":"36","author":"B Ravikumar","year":"2004","unstructured":"Ravikumar B, et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet. 2004;36:585.","journal-title":"Nat Genet"},{"key":"420_CR44","doi-asserted-by":"publisher","first-page":"e9313","DOI":"10.1371\/journal.pone.0009313","volume":"5","author":"L Crews","year":"2010","unstructured":"Crews L, et al. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of \u03b1-synucleinopathy. PLoS One. 2010;5:e9313.","journal-title":"PLoS One"},{"key":"420_CR45","doi-asserted-by":"publisher","first-page":"e9979","DOI":"10.1371\/journal.pone.0009979","volume":"5","author":"P Spilman","year":"2010","unstructured":"Spilman P, et al. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-\u03b2 levels in a mouse model of Alzheimer\u2019s disease. PLoS One. 2010;5:e9979.","journal-title":"PLoS One"},{"key":"420_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI78652","volume":"125","author":"G Kroemer","year":"2015","unstructured":"Kroemer G. Autophagy: a druggable process that is deregulated in aging and human disease. J Clin Invest. 2015;125:1\u20134.","journal-title":"J Clin Invest"},{"key":"420_CR47","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023.","journal-title":"Signal Transduct Target Ther"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-020-00420-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13024-020-00420-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-020-00420-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T18:14:41Z","timestamp":1610043281000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-020-00420-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["420"],"URL":"https:\/\/doi.org\/10.1186\/s13024-020-00420-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-29102\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-29102\/v2","asserted-by":"object"}]},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"15 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JPJ holds shares in IMSTAR Therapeutics which provided the IMS-088 compound. All other authors have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}